| 38091011 | Clinical Outcomes After Traumatic Brain Injury and Exposure to Extracranial Surgery: A TRACK-TBI Study. | JAMA Surg | 2024 |
| 34279565 | Pathological Computed Tomography Features Associated With Adverse Outcomes After Mild Traumatic Brain Injury: A TRACK-TBI Study With External Validation in CENTER-TBI. | JAMA Neurol | 2021 |
| 33822070 | Association of Sex and Age With Mild Traumatic Brain Injury-Related Symptoms: A TRACK-TBI Study. | JAMA Netw Open | 2021 |
| 33783518 | Latent Profile Analysis of Neuropsychiatric Symptoms and Cognitive Function of Adults 2 Weeks After Traumatic Brain Injury: Findings From the TRACK-TBI Study. | JAMA Netw Open | 2021 |
| 34964854 | Association of Posttraumatic Epilepsy With 1-Year Outcomes After Traumatic Brain Injury. | JAMA Netw Open | 2021 |
| 34228047 | Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study. | JAMA Neurol | 2021 |
| 30375265 | Response to Foks et al. (doi: 10.1089/neu.2018.5979): Why Our Long-Term Functional Prognosis Tools are a Valuable Contribution to the Traumatic Brain Injury Outcome Literature. | J Neurotrauma | 2019 |
| 30234849 | Using Decision Tree Methodology to Predict Employment After Moderate to Severe Traumatic Brain Injury. | J Head Trauma Rehabil | 2019 |
| 31157856 | Recovery After Mild Traumatic Brain Injury in Patients Presenting to US Level I Trauma Centers: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Study. | JAMA Neurol | 2019 |
| 29566600 | Predicting Long-Term Global Outcome after Traumatic Brain Injury: Development of a Practical Prognostic Tool Using the Traumatic Brain Injury Model Systems National Database. | J Neurotrauma | 2018 |
| 30646055 | Assessment of Follow-up Care After Emergency Department Presentation for Mild Traumatic Brain Injury and Concussion: Results From the TRACK-TBI Study. | JAMA Netw Open | 2018 |
| 29421963 | Making Football Safer: Assessing the Current National Football League Policy on the Type of Helmets Allowed on the Playing Field. | J Neurotrauma | 2018 |
| 25841982 | Altered white matter in cocaine-dependent subjects with traumatic brain injury: A diffusion tensor imaging study. | Drug Alcohol Depend | 2015 |
| 26485478 | Nutritional Supplementation with Chlorella pyrenoidosa Lowers Serum Methylmalonic Acid in Vegans and Vegetarians with a Suspected Vitamin Bâ¿â¿¿ Deficiency. | J Med Food | 2015 |
| 25285596 | The effect of oral care on intracranial pressure in critically ill adults. | J Neurosci Nurs | 2014 |
| 23168823 | Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). | JAMA | 2012 |
| 19803786 | The citicoline brain injury treatment (COBRIT) trial: design and methods. | J Neurotrauma | 2009 |
| 15933813 | Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas. | J Neurooncol | 2005 |
| 12864971 | Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery. | J Neuroimmunol | 2003 |
| 12952285 | Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression. | J Neurooncol | 2003 |
| 12012105 | Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination. | Cancer Immunol Immunother | 2002 |
| 15916412 | Outcome measures for clinical trials in neurotrauma. | Neurosurg Focus | 2002 |
| 12635661 | Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat. | J Neurooncol | 2002 |
| 12495586 | Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. | J Med Food | 2002 |
| 12012106 | Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression. | Cancer Immunol Immunother | 2002 |
| 11123284 | IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity. | J Immunol | 2001 |
| 11347287 | A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. | Altern Ther Health Med | 2001 |
| 11570581 | Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis. | Cancer Immunol Immunother | 2001 |
| 10815009 | Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study. | Phytother Res | 2000 |
| 10668412 | A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury. | Ann N Y Acad Sci | 1999 |
| 10845391 | Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats. | J Neurooncol | 1999 |
| 10668413 | An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage. | Ann N Y Acad Sci | 1999 |
| 9049859 | Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes. | J Neurooncol | 1997 |
| 9176405 | Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. | Am J Pathol | 1997 |
| 9175143 | Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes. | Neurol Res | 1997 |
| 9006660 | Effects of an intratumoral injection of human recombinant tumor necrosis factor-alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model. | Acta Neuropathol | 1997 |
| 9049860 | Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes. | J Neurooncol | 1997 |
| 7825184 | The effects of acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on glioma-specific cytotoxic T-cell activity in Fischer 344 rats. | Toxicology | 1995 |
| 7807180 | Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. | J Neurooncol | 1994 |
| 8121549 | Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines. | Neurosurgery | 1994 |
| 1285500 | Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-alpha in the rat. | Acta Neuropathol | 1992 |
| 1641114 | Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma. | Neurosurgery | 1992 |
| 1739983 | Corticosteroids inhibit the delivery of short-term activational pulses of phorbol ester and calcium ionophore to human peripheral T cells. | Cell Immunol | 1992 |
| 1613537 | Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat. | J Neurooncol | 1992 |
| 1541981 | Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial. | J Neurooncol | 1992 |
| 1730954 | In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect. | J Neurosurg | 1992 |
| 1367404 | A comparison of serum-free media for the support of in vitro mitogen-induced blastogenic expansion of cytolytic lymphocytes. | Cytotechnology | 1991 |
| 1874974 | Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats. | J Neuroimmunol | 1991 |
| 1716671 | Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model. | J Neurooncol | 1991 |
| 2089914 | Effect of murine recombinant interleukin-1 on brain oedema in the rat. | Acta Neurochir Suppl (Wien) | 1990 |